Skip to main content
Top
Published in: Rheumatology International 8/2013

01-08-2013 | Original Article

Apoptosis-related Fas and FasL gene polymorphisms’ associations with knee osteoarthritis

Authors: Melek Sezgin, İbrahim Ömer Barlas, Seyfi Yıldır, Gözde Türköz, Handan Çamdeviren Ankaralı, Günşah Şahin, Mehmet Emin Erdal

Published in: Rheumatology International | Issue 8/2013

Login to get access

Abstract

To investigate the associations between Fas and FasL gene polymorphisms and susceptibility to knee osteoarthritis. Genomic DNA was obtained from 146 patients with knee osteoarthritis and 102 healthy controls. Genotype distributions and allelic frequencies of four polymorphisms of Fas (-670 G>A rs1800682, -1377 G>A rs2234767) and FasL (IVS2nt-124 A>G rs5030772, -844 T>C rs763110) genes were compared between the groups. Thereafter, this association was investigated between patients and controls of the same sex. There were significant differences between patients with knee osteoarthritis and controls regarding the genotype distributions and allelic frequencies of Fas-1377 G>A polymorphism (P = 0.0001 and P = 0.005, respectively). The Fas-1377 GG genotype and G allele were significantly more frequent in patients with knee osteoarthritis than in controls. Genotype distributions and allelic frequencies of Fas-670 G>A, FasL-844 T>C, and FasL IVS2nt-124 A>G polymorphisms did not differ between the groups (P > 0.05). However, there were no significant differences between patients and controls of the same sex (P > 0.05). These findings suggest that the Fas-1377 G>A polymorphism in the Fas gene related with apoptosis may contribute to susceptibility to knee osteoarthritis in the Turkish population. There is a need for further studies to evaluate the role of apoptosis in large cohorts.
Literature
1.
go back to reference Hamerman D (1993) Aging and osteoarthritis: basic mechanisms. J Am Geriatr Soc 41:760–770PubMed Hamerman D (1993) Aging and osteoarthritis: basic mechanisms. J Am Geriatr Soc 41:760–770PubMed
2.
go back to reference Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254–272PubMedCrossRef Westacott CI, Sharif M (1996) Cytokines in osteoarthritis: mediators or markers of joint destruction? Semin Arthritis Rheum 25:254–272PubMedCrossRef
3.
4.
go back to reference Sharif M, Whitehouse A, Sharman P, Perry M, Adams M (2004) Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 50:507–515PubMedCrossRef Sharif M, Whitehouse A, Sharman P, Perry M, Adams M (2004) Increased apoptosis in human osteoarthritic cartilage corresponds to reduced cell density and expression of caspase-3. Arthritis Rheum 50:507–515PubMedCrossRef
5.
go back to reference Aigner T, Kim HA (2002) Apoptosis and cellular vitality: issues in osteoarthritic cartilage degradation. Arthritis Rheum 46:1986–1996PubMedCrossRef Aigner T, Kim HA (2002) Apoptosis and cellular vitality: issues in osteoarthritic cartilage degradation. Arthritis Rheum 46:1986–1996PubMedCrossRef
6.
go back to reference Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A (2002) Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J 166:140–158CrossRef Goggs R, Carter SD, Schulze-Tanzil G, Shakibaei M, Mobasheri A (2002) Apoptosis and the loss of chondrocyte survival signals contribute to articular cartilage degradation in osteoarthritis. Vet J 166:140–158CrossRef
7.
go back to reference Lotz M, Hashimoto S, Kuhn K (1999) Mechanisms of chondrocyte apoptosis. Osteoarthr Cartil 7:389–391PubMedCrossRef Lotz M, Hashimoto S, Kuhn K (1999) Mechanisms of chondrocyte apoptosis. Osteoarthr Cartil 7:389–391PubMedCrossRef
8.
go back to reference Mobasheri A (2002) Role of chondrocyte death and hypocellularity in aging human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses 58:193–197PubMedCrossRef Mobasheri A (2002) Role of chondrocyte death and hypocellularity in aging human articular cartilage and the pathogenesis of osteoarthritis. Med Hypotheses 58:193–197PubMedCrossRef
9.
go back to reference Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F (1998) Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 41:284–289PubMedCrossRef Blanco FJ, Guitian R, Vazquez-Martul E, de Toro FJ, Galdo F (1998) Osteoarthritis chondrocytes die by apoptosis: a possible pathway for osteoarthritis pathology. Arthritis Rheum 41:284–289PubMedCrossRef
10.
go back to reference Heraud F, Heraud A, Harmand MF (2000) Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59:959–965PubMedCrossRef Heraud F, Heraud A, Harmand MF (2000) Apoptosis in normal and osteoarthritic human articular cartilage. Ann Rheum Dis 59:959–965PubMedCrossRef
11.
go back to reference Kim HA, Suh DI, Song YW (2001) Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage. J Rheumatol 28:2038–2045PubMed Kim HA, Suh DI, Song YW (2001) Relationship between chondrocyte apoptosis and matrix depletion in human articular cartilage. J Rheumatol 28:2038–2045PubMed
12.
go back to reference Pennock AT, Robertson CM, Emmerson BC, Harwood FL, Amiel D (2007) Role of apoptotic and matrix-degrading genes in articular cartilage and meniscus of mature and aged rabbits during development of osteoarthritis. Arthritis Rheum 56:1529–1536PubMedCrossRef Pennock AT, Robertson CM, Emmerson BC, Harwood FL, Amiel D (2007) Role of apoptotic and matrix-degrading genes in articular cartilage and meniscus of mature and aged rabbits during development of osteoarthritis. Arthritis Rheum 56:1529–1536PubMedCrossRef
13.
go back to reference Alenzi FQ (2005) Apoptosis and diseases: regulation and clinical relevance. Saudi Med J 26:1679–1690PubMed Alenzi FQ (2005) Apoptosis and diseases: regulation and clinical relevance. Saudi Med J 26:1679–1690PubMed
14.
go back to reference D’Lima DD, Hashimoto S, Chen PC, Lotz MK, Colwell CW Jr (2001) Prevention of chondrocyte apoptosis. J Bone Joint Surg Am 83:25–26PubMed D’Lima DD, Hashimoto S, Chen PC, Lotz MK, Colwell CW Jr (2001) Prevention of chondrocyte apoptosis. J Bone Joint Surg Am 83:25–26PubMed
15.
go back to reference Kim HA, Lee YJ, Seong SC, Choe KW, Song YW (2000) Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27:455–462PubMed Kim HA, Lee YJ, Seong SC, Choe KW, Song YW (2000) Apoptotic chondrocyte death in human osteoarthritis. J Rheumatol 27:455–462PubMed
16.
go back to reference Musumeci G, Loreto C, Carnazza ML, Martinez G (2011) Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee Surg Sports Traumatol Arthrosc 192:307–313CrossRef Musumeci G, Loreto C, Carnazza ML, Martinez G (2011) Characterization of apoptosis in articular cartilage derived from the knee joints of patients with osteoarthritis. Knee Surg Sports Traumatol Arthrosc 192:307–313CrossRef
17.
go back to reference Itoh N, Yonehara S, Ishii A et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243PubMedCrossRef Itoh N, Yonehara S, Ishii A et al (1991) The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66:233–243PubMedCrossRef
18.
go back to reference Oehm A, Behrmann I, Falk W et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. sequence identity with the Fas antigen. J Biol Chem 267:10709–10715PubMed Oehm A, Behrmann I, Falk W et al (1992) Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily. sequence identity with the Fas antigen. J Biol Chem 267:10709–10715PubMed
19.
go back to reference Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34:577–582PubMedCrossRef Huang QR, Morris D, Manolios N (1997) Identification and characterization of polymorphisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol 34:577–582PubMedCrossRef
20.
go back to reference Sibley K, Rollinson S, Allan JM et al (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327–4330PubMed Sibley K, Rollinson S, Allan JM et al (2003) Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327–4330PubMed
21.
go back to reference Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC (2003) A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 70:132–138 Wu J, Metz C, Xu X, Abe R, Gibson AW, Edberg JC (2003) A novel polymorphic CAAT/enhancer-binding protein beta element in the FasL gene promoter alters Fas ligand expression: a candidate background gene in African American systemic lupus erythematosus patients. J Immunol 70:132–138
22.
go back to reference Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243–269PubMedCrossRef Cohen PL, Eisenberg RA (1991) Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu Rev Immunol 9:243–269PubMedCrossRef
23.
go back to reference Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R (2000) Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer 82:1682–1688PubMedCrossRef Das H, Koizumi T, Sugimoto T, Chakraborty S, Ichimura T, Hasegawa K, Nishimura R (2000) Quantitation of Fas and Fas ligand gene expression in human ovarian, cervical and endometrial carcinomas using real-time quantitative RT-PCR. Br J Cancer 82:1682–1688PubMedCrossRef
24.
go back to reference Mohammadzadeh A, Pourfathollah AA, Tahoori MT, Daneshmandi S, Langroudi L, Akhlaghi M (2011) Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int 31. doi:10.1007/s00296-011-2065-x Mohammadzadeh A, Pourfathollah AA, Tahoori MT, Daneshmandi S, Langroudi L, Akhlaghi M (2011) Evaluation of apoptosis-related gene Fas (CD95) and FasL (CD178) polymorphisms in Iranian rheumatoid arthritis patients. Rheumatol Int 31. doi:10.​1007/​s00296-011-2065-x
25.
go back to reference Wang LE, Cheng L, Spitz MR, Wei Q (2003) Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 42:1–8PubMedCrossRef Wang LE, Cheng L, Spitz MR, Wei Q (2003) Fas A670G polymorphism, apoptotic capacity in lymphocyte cultures, and risk of lung cancer. Lung Cancer 42:1–8PubMedCrossRef
26.
go back to reference Lai HC, Sytwu HK, Sun CA et al (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103:221–225PubMedCrossRef Lai HC, Sytwu HK, Sun CA et al (2003) Single nucleotide polymorphism at Fas promoter is associated with cervical carcinogenesis. Int J Cancer 103:221–225PubMedCrossRef
27.
go back to reference Zhu J, Qin C, Wang M et al (2010) Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol Carcinog 49:810–817PubMed Zhu J, Qin C, Wang M et al (2010) Functional polymorphisms in cell death pathway genes and risk of renal cell carcinoma. Mol Carcinog 49:810–817PubMed
28.
go back to reference Li C, WuW Liu J et al (2006) Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case–control analysis. Pharmacogenet Genomics 16:245–251PubMedCrossRef Li C, WuW Liu J et al (2006) Functional polymorphisms in the promoter regions of the FAS and FAS ligand genes and risk of bladder cancer in south China: a case–control analysis. Pharmacogenet Genomics 16:245–251PubMedCrossRef
29.
go back to reference Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genes FAS and FASL in esophageal squamous cell carcinoma. J Natl Cancer Inst 96:1030–1036PubMedCrossRef Sun T, Miao X, Zhang X, Tan W, Xiong P, Lin D (2004) Polymorphisms of death pathway genes FAS and FASL in esophageal squamous cell carcinoma. J Natl Cancer Inst 96:1030–1036PubMedCrossRef
30.
go back to reference Chen JY, Wang CM, Ma CC, Chow YH, Luo SF (2005) The _844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun 6:123–128PubMedCrossRef Chen JY, Wang CM, Ma CC, Chow YH, Luo SF (2005) The _844C/T polymorphism in the Fas ligand promoter associates with Taiwanese SLE. Genes Immun 6:123–128PubMedCrossRef
31.
go back to reference Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215PubMedCrossRef Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16(3):1215PubMedCrossRef
32.
go back to reference Fuks A, Parton LA, Polavarapu S, Netta D, Strassberg S, Godi I, Hsu CD (2005) Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 193:1132–1136PubMedCrossRef Fuks A, Parton LA, Polavarapu S, Netta D, Strassberg S, Godi I, Hsu CD (2005) Polymorphism of Fas and Fas ligand in preterm premature rupture of membranes in singleton pregnancies. Am J Obstet Gynecol 193:1132–1136PubMedCrossRef
33.
go back to reference Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G (2005) The-670A>G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C. J Viral Hepat 12:568–573PubMedCrossRef Aguilar-Reina J, Ruiz-Ferrer M, Pizarro MA, Antiñolo G (2005) The-670A>G polymorphism in the promoter region of the FAS gene is associated with necrosis in periportal areas in patients with chronic hepatitis C. J Viral Hepat 12:568–573PubMedCrossRef
34.
go back to reference Li C, Larson D, Zhang Z et al (2006) Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253–263PubMedCrossRef Li C, Larson D, Zhang Z et al (2006) Polymorphisms of the FAS and FAS ligand genes associated with risk of cutaneous malignant melanoma. Pharmacogenet Genomics 16:253–263PubMedCrossRef
35.
go back to reference Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42:479–484PubMedCrossRef Zhang X, Miao X, Sun T, Tan W, Qu S, Xiong P, Zhou Y, Lin D (2005) Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42:479–484PubMedCrossRef
36.
go back to reference Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K (2003) Fas ligand gene polymorphisms are not associated with Hashimoto’s thyroiditis and Graves’ disease. Hum Immunol 64:285–289PubMedCrossRef Stuck BJ, Pani MA, Besrour F, Segni M, Krause M, Usadel KH, Badenhoop K (2003) Fas ligand gene polymorphisms are not associated with Hashimoto’s thyroiditis and Graves’ disease. Hum Immunol 64:285–289PubMedCrossRef
37.
go back to reference Hashimoto S, Setareh M, Ochs RL, Lotz M (1997) Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 40:1749–1755PubMedCrossRef Hashimoto S, Setareh M, Ochs RL, Lotz M (1997) Fas/Fas ligand expression and induction of apoptosis in chondrocytes. Arthritis Rheum 40:1749–1755PubMedCrossRef
38.
go back to reference Robertson CM, Pennock AT, Harwood FL, Pomerleau AC, Allen RT, Amiel D (2006) Characterization of pro-apoptotic and matrix-degradative gene expression following induction of osteoarthritis in mature and aged rabbits. Osteoarthritis Cartilage 14:471–476PubMedCrossRef Robertson CM, Pennock AT, Harwood FL, Pomerleau AC, Allen RT, Amiel D (2006) Characterization of pro-apoptotic and matrix-degradative gene expression following induction of osteoarthritis in mature and aged rabbits. Osteoarthritis Cartilage 14:471–476PubMedCrossRef
39.
go back to reference Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J (2002) A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29:1183–1188PubMed Kanemitsu S, Ihara K, Saifddin A, Otsuka T, Takeuchi T, Nagayama J (2002) A functional polymorphism in fas (CD95/APO-1) gene promoter associated with systemic lupus erythematosus. J Rheumatol 29:1183–1188PubMed
Metadata
Title
Apoptosis-related Fas and FasL gene polymorphisms’ associations with knee osteoarthritis
Authors
Melek Sezgin
İbrahim Ömer Barlas
Seyfi Yıldır
Gözde Türköz
Handan Çamdeviren Ankaralı
Günşah Şahin
Mehmet Emin Erdal
Publication date
01-08-2013
Publisher
Springer Berlin Heidelberg
Published in
Rheumatology International / Issue 8/2013
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-013-2688-1

Other articles of this Issue 8/2013

Rheumatology International 8/2013 Go to the issue